OREANDA-NEWS. On March 20, 2007 Bio Life Remedies, Inc. (PINKSHEETS: BLRS) announces that LehmanBrown, an international accounting firm, had conducted an evaluation on the company based on two of its diabetic products, Zutrol™ and Betatrol™, reported the press-centre of  Bio Life Remedies, Inc.

The company's President and CEO, Jack Guo commented, "The value shown by the report is really an indication of the company's great potential; and I believe the company will grow rapidly as we build up the market channel and introduce more products to consolidate our product base."